Quick Search

PRODUCTS

E630 (lNOSINIC ACID)

CAS NUMBER: 131-99-7

MOLECULAR FORMULA: C10H13N4O8P

MOLECULAR WEIGHT: 348.206 g/mol


E630 (Inosinic acid) is a nucleotide (that is, a nucleoside monophosphate). 
E630 (Inosinic acid) is widely used as a flavor enhancer.

E630 (Inosinic acid) is typically obtained from chicken byproducts or other meat industry waste. 
E630 (Inosinic acid) is important in metabolism. 

E630 (Inosinic acid) is the ribonucleotide of hypoxanthine and the first nucleotide formed during the synthesis of purine nucleotides. 
E630 (Inosinic acid) can also be formed by the deamination of adenosine monophosphate by AMP deaminase. 

E630 (Inosinic acid) can be hydrolysed to inosine.
Important derivatives of inosinic acid include the purine nucleotides found in nucleic acids and adenosine triphosphate, which is used to store chemical energy in muscle and other tissues.

In the food industry, inosinic acid and its salts such as disodium inosinate are used as flavor enhancers.

The inosinate synthesis is complex, beginning with a 5-phosphoribosyl-1-pyrophosphate (PRPP). 
Enzymes taking part in E630 (Inosinic acid) synthesis constitute a multienzyme complex in the cell. 

Evidence demonstrates that there are multifunctional enzymes, and some of them catalyze non-sequential steps in the pathway.
E630 (Inosinic acid)s inhibit the synthesis of 5-phosphoribosylamine from 5-phosphoribosyl-1-pyrophosphate (PRPP), disabling the enzyme that catalyzes the reaction: glutamine-5-phosphoribosyl-1-pyrophosphate-amidotransferase. 

In other words, when levels of inosinate are high, glutamine-5-phosphoribosyl-1-pyrophosphate-amidotransferase is inhibited, and, as a consequence, inosinate levels decrease. 
Also, as a result, adenylate and guanylate are not produced, which means that RNA synthesis cannot be completed because of the lack of these two important RNA nucleotides.

E630 (Inosinic acid) is a natural product found in Corynebacterium ammoniagenes, Synechococcus elongatus, and other organisms
E630 (Inosinic acid) is a metabolite found in the aging.

E630 (Inosinic acid) is a purine ribonucleoside 5'-monophosphate and an inosine phosphate. 
E630 (Inosinic acid) is a conjugate acid of an IMP(2-).

E630 (Inosinic acid) can also be formed by the deamination of adenosine monophosphate by AMP deaminase. 
E630 (Inosinic acid) is formed by the inosinate oxidation to xanthylate.

E630 (Inosinic acid) participates in a number of enzymatic reactions. 
In particular, inosinic acid can be converted into phosphoribosyl formamidocarboxamide; which is catalyzed by the bifunctional purine biosynthesis protein. 

In addition, inosinic acid can be converted into xanthylic acid.
E630 (Inosinic acid) is important in metabolism. 

E630 (Inosinic acid) is the ribonucleotide of hypoxanthine and the first nucleotide formed during the synthesis of purine nucleotides.
E630 (Inosinic acid) is an important compound in metabolism. 

E630 (Inosinic acid) is the ribonucleotide of hypoxanthine and is the first compound formed during the synthesis of purine in organisms. 
From inosinic acid are derived such important compounds as the purine nucleotides found in nucleic acids and the energy-rich purine nucleotide adenosine triphosphate, in which chemical energy is stored in cells.

E630 (Inosinic acid) belongs to the class of organic compounds known as purine ribonucleoside monophosphates. 
These are nucleotides consisting of a purine base linked to a ribose to which one monophosphate group is attached. 

E630 (Inosinic acid) is an extremely weak basic (essentially neutral) compound (based on its pKa).
E630 (Inosinic acid) is typically obtained from chicken byproducts or other meat industry waste. 

E630 (Inosinic acid) is important in metabolism. 
E630 (Inosinic acid) is the ribonucleotide of hypoxanthine and the first nucleotide formed during the synthesis of purine nucleotides. 

E630 (Inosinic acid) can also be formed by the deamination of adenosine monophosphate by AMP deaminase. 
E630 (Inosinic acid) can be hydrolysed to inosine. 

In the food industry, inosinic acid and its salts such as disodium inosinate are used as flavor enhancers. 
E630 (Inosinic acid) is known as E number reference E630.

E630 (Inosinic acid) is a purine nucleotide which has hypoxanthine as the base and one phosphate group esterified to the sugar moiety. 
E630 (Inosinic acid) is a nucleotide present in muscle and other tissues. 

E630 (Inosinic acid) is formed by the deamination of AMP and when hydrolysed produces inosine. 
E630 (Inosinic acid) is the ribonucleotide of hypoxanthine and is the first compound formed during the synthesis of purine.

Inosine 5′-monophosphate (IMP) is used as a substrate to study the distribution, specificity and kinetics of inosine-5′-monophosphate dehydrogenase (IMPDH).
E630 (Inosinic acid) is a purine nucleotide which has hypoxanthine as the base and one phosphate group esterified to the sugar moiety. 

E630 (Inosinic acid) is a nucleotide present in muscle and other tissues. 
E630 (Inosinic acid) is formed by the deamination of AMP and when hydrolysed produces inosine. 

E630 (Inosinic acid) is the ribonucleotide of hypoxanthine and is the first compound formed during the synthesis of purine.
E630 (Inosinic acid) is used as a substrate to study the distribution, specificity and kinetics of inosine-5′-monophosphate dehydrogenase (IMPDH).

E630 (Inosinic acid) is a purine nucleotides which has one phosphate group esterified to the sugar moiety and hypoxanthine as the base. 
E630 (Inosinic acid) is the parent substance of two purine nucleotides, guanylic acid and adenylic acid which are a component of nucleic acid. 

E630 (Inosinic acid) is nucleoside which is important in body metabolism.
E630 (Inosinic acid) is also prepared from bacterial fermentation of sugar. 

Being primarily employed in the food industry as a food additive, inosinic acid is very effective as a flavor enhancer. 
E630 (Inosinic acid) is also used to balance the taste of meat.

A drawback of inosinic acid is noted that the conversion of inosinic acid to uric acid in the human body. 
Thus, the occurrence of inosinic acid leads to gout in several cases leading to health concerns from the consumers and governing authorities.

E630 (Inosinic acid) gives acts as a better flavor enhancer in the food & beverage industry and can be said to outperform numerous food additives available in the market. 
This is anticipated to primarily drive the inosinic acid market, globally.

Rising prominence of inosinic acid as a sweetener in the confectionary goods also drives the growth in the global inosinic acid. 
Added applications in the baked products are also termed to grow the demand for inosinic acid. E630 (Inosinic acid), as a sweetener, in the manufacture of pharmaceutical drugs including cough syrups is fueling the growth of inosinic acid.

As the production of inosinic acid involves the use of fish and meat, this acts as a restraining factor due to consumer preferences preferring vegan products. 
E630 (Inosinic acid) also increases the risk of gout.

E630 (Inosinic acid) is a purine nucleotides which has one phosphate group esterified to the sugar moiety and hypoxanthine as the base. 
E630 (Inosinic acid) is the parent substance of two purine nucleotides, guanylic acid and adenylic acid which are a component of nucleic acid. 

E630 (Inosinic acid) is nucleoside which is important in body metabolism. 
E630 (Inosinic acid) is formed due to hydrolyzed produced inosinic and result in deamination of AMP.

E630 (Inosinic acid) is primarily present in animals and is commercially is prepared from bacterial fermentation or yeast as well as fish, meat, shellfish and can also be produced by bacterial fermentation of sugars.
Primarily application of inosinic acid is used as a food additive and has high effectiveness as a flavor enhancer as well as to balance the taste of meat. 

The inosinic acid in the human body is degraded to uric acid. Thus, the occurrence of uric acid can lead to gout.
E630 (Inosinic acid) provides more enhanced flavor in the application products and thus outperforms in the food additive market. 

E630 (Inosinic acid) is the prime factor driving global inosinic market.
Moreover, application in products as a sweetener in the baked goods is growing the inosinic acid market.

E630 (Inosinic acid) or inosine monophosphate (IMP) is a nucleotide (that is, a nucleoside monophosphate). 
E630 (Inosinic acid) is typically obtained from chicken byproducts or other meat industry waste. 

E630 (Inosinic acid) is important in metabolism. 
E630 (Inosinic acid) is the ribonucleotide of hypoxanthine and the first nucleotide formed during the synthesis of purine nucleotides. 

E630 (Inosinic acid) can also be formed by the deamination of adenosine monophosphate by AMP deaminase. 
E630 (Inosinic acid) can be hydrolysed to inosine. 

The enzyme deoxyribonucleoside triphosphate pyrophosphohydrolase, encoded by YJR069C in Saccharomyces cerevisiae and containing.
E630 (Inosinic acid), also known as inosine monophosphate, is a vital acid in metabolism andit is usually found in different muscles. 

E630 (Inosinic acid) is a colorless and odorless compound that comes in both crystaland powder form.
E630 (Inosinic acid), also known as primary nucleotide, is formed during the synthesis of purine and can be transformed into salts, such as disodium inosinate, dipotassium inosinate and calcium inosinate.

E630 (Inosinic acid) can beproduced by deamination of adenosine monophosphate (AMP) but is commercially manufacturedby fermentation of bacteria or yeast as well as fish, meat, and shellfish.
Surge in utilization of inosinic acid as a flavor enhancer in the food &beverage segments is anticipated to fuel the growth of the global inosinic acid market. 

Further, usage of inosinic acid as sweetener in the confectionary goodsisexpected to boost the segment growth during the forecast period. 
However, high consumption of E630 (Inosinic acid) can lead to deposition of uric acid in blood and urine causing health issues such as kidney damage and bladder stones.

Nonetheless, rise in prominence in research and development (R&D) coupled with new product developments are anticipated to provide new opportunities over the upcoming period. 
The inosinic acid market is segmented into derived salts, application, enduser, and region. 

By type, the market is divided into disodium inosinate, dipotassium inosinate,and dicalcium inosinate. 
By application, the market is fragmented into flavor enhancer, meat, cough syrups, sauce, supplements, and others. 

By enduser,the market is differentiated intofood &beverages, confectionary, pharmaceuticals,and others.
E630 (Inosinic acid) is used as flavor enhancer in the cough syrup to suppress the original flavor.

E630 (Inosinic acid) is a nucleoside monophosphate. 
E630 (Inosinic acid) is important in metabolism. 

E630 (Inosinic acid) is the ribonucleotide of hypoxanthine and the first nucleotide formed during the synthesis of purine. 
E630 (Inosinic acid) is formed by the deamination of adenosine monophosphate, and is hydrolysed from inosine. 

E630 (Inosinic acid) is an intermediate ribonucleoside monophosphate in purine metabolism. 
In the food industry, inosinic acid and its salts such as disodium inosinate are used as flavour enhancers.

E630 (Inosinic acid) is a purine nucleotide which has hypoxanthine as the base and one phosphate group esterified to the sugar moiety. 
E630 (Inosinic acid) is a nucleotide present in muscle and other tissues.

E630 (Inosinic acid) is formed by the deamination of AMP and when hydrolysed produces inosine. 
E630 (Inosinic acid) is the ribonucleotide of hypoxanthine and is the first compound formed during the synthesis of purine. 

E630 (Inosinic acid) or inosine monophosphate (IMP) is a nucleotide monophosphate. 
E630 (Inosinic acid) is important in metabolism. 

E630 (Inosinic acid) is the ribonucleotide of hypoxanthine and the first nucleotide formed during the synthesis of purine. 
E630 (Inosinic acid) is formed by the deamination of adenosine monophosphate, and is hydrolysed from inosine. 

E630 (Inosinic acid) is an intermediate ribonucleoside monophosphate in purine metabolism.
E630 (Inosinic acid) is a nucleotide (that is, a nucleoside monophosphate). 

E630 (Inosinic acid) has been used as an umami tastant along with MSG to study their cortical responses and interactions in the human brain. 
E630 (Inosinic acid) may be used as a substrate to study the distribution, specificity, and kinetics of inosine-5′-monophosphate dehydrogenase.

E630 (Inosinic acid) is a purine nucleotide with a flavor-enhancing property. 
E630 (Inosinic acid) acts as a precursor for the synthesis of both guanosine monophosphate (GMP) and adenosine monophosphate (AMP).

APPLICATION:

E630 (Inosinic acid) can be converted into various salts including disodium inosinate (E631), dipotassium inosinate (E632), and calcium inosinate (E633). 
E630 (Inosinic acid)s are used as flavor enhancers for the basic taste umami with a comparatively high effectiveness. 
E630 (Inosinic acid)s are mostly used in soups, sauces, and seasonings for the intensification and balance of the flavor of meat. 

FUNCTION:

E630 (Inosinic acid) is a nucleotide (that is, a nucleoside monophosphate). 
E630 (Inosinic acid) is typically obtained from chicken byproducts or other meat industry waste. 
E630 (Inosinic acid) is important in metabolism.

WHERE IS INOSINIC ACID FOUND:

E630 (Inosinic acid) is a natural product.
E630 (Inosinic acid) is a metabolite found in the aging mouse brain. 
E630 (Inosinic acid) is a purine ribonucleoside 5'-monophosphate having hypoxanthine as the nucleobase.

SYNONYM:

5'-IMP
5'-Inosinate
5'-Inosine monophosphate
5'-E630 (Inosinic acid)
IMP
Inosine 5'-monophosphate
Inosine 5'-phosphate
Inosine Monophosphate
Inosine-5'-monophosphate
2'-Inosine-5'-monophosphate
Hypoxanthosine 5'-monophosphate
Ribosylhypoxanthine monophosphate
2'-Inosine-5'-monophosphoric acid
5'-Inosine monophosphoric acid
Hypoxanthosine 5'-monophosphoric acid
Inosine 5'-monophosphoric acid
Inosine 5'-phosphoric acid
Inosine monophosphoric acid
Ribosylhypoxanthine monophosphoric acid
Inosinate
E630 (Inosinic acid)s
Inosinate, sodium
monoPhosphate, inosine
monoPhosphate, ribosylhypoxanthine
Sodium inosinate
Acid, inosinic
Acids, inosinic

  • Share !
E-NEWSLETTER